New approach aligns with long-standing biosimilar strategy

December 2024 December 2023 June 2024 December 2021 Pharmacy newsletter from Prime Therapeutics that provides information and updates about Prime services. June 2022 Home Other Navigation Pharmacy...

publications Fall 2024 Prime Therapeutics Report October 21, 2024 Debuting a new name and design, the 41st edition of our managed care report still offers the same in-depth industry articles on...

publications Summer 2024 Prime Therapeutics Report June 11, 2024 The Prime Therapeutics Report is your source for innovative managed care strategies, trends and updates. This issue’s cover story...

Reimagining pharmacy for our loved ones Please enter a valid video URL. The URL can point to any video file or a Youtube video. View playlist Please enter a valid video URL. The URL can point to...

Expert Clinical Insights Metastatic Melanoma MEDICATION INSIGHTS: Lifileucel (Amtagvi™) The U.S. Food and Drug Administration (FDA) approved lifileucel (Amtagvi™) in February 2024 through the...

Abby Kim, PharmD, BCOP, is a senior director, clinical strategy and oncology specialty solutions, shares key takeaways from the American Journal of Managed Care (AJMC) forum, “Bridging evidence and...

image from Healthcare Advocate Summit Prerak Parikh represented Prime on a panel at Healthcare Advocate Summit 2025 in Las Vegas on Sept. 4 with other payer/PBM professionals Prime Therapeutics At...

Annual conference features presentations, panels, discussions and networking

The American Journal of Managed Care (AJMC): At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection,...

Second annual report gives a transparent overview of Prime’s organizational makeup, highlights milestones along its journey

Hear the first part of a two-part preview of the research the Prime Therapeutics health outcomes team will present at the annual managed care pharmacy event

cover image for MPTR blog Prime expert shares exciting enhancement to Medical Pharmacy Trend Report Lisa Polakowski Lisa Polakowski, PharmD, is the Medical Pharmacy Trend Report director for Prime...

Latest edition of Prime Therapeutics Report spotlights seismic shift in how best to diagnose and manage transthyretin amyloid cardiomyopathy (ATTR-CM) and what it means for patients, providers and...

New indications for approved traditional drugs - 2025 Generic name Brand name Manufacturer Indication(s) Route of administration Month approved* zopapogene imadenovec-drba Papzimeos Precigen...

AAVRh74var adeno-associated virus serotype Rh74var ABSSSI acute bacterial skin and skin structure infections AChR acetylcholine receptor ADHD attention deficit hyperactivity disorder ALK anaplastic...

New indications for approved gene and cellular therapy products - 2025 Generic name Brand name Manufacturer Indication(s) Route of administration Month approved* prademagene zamikeracel Zevaskyn...

*Disclaimer: Date indicates FDA approval date only. The product launch and marketing dates are determined by the approved product’s manufacturer. All brand names are property of their respective...

Generic name Brand name Manufacturer Indication(s) Route of administration Month approved* diazoxide choline Vykat XR Soleno Hyperphagia in Prader-Willi syndrome (≥ 4 years of age) Oral March...

publications Quarterly Drug Approvals: October 2024 This report provides an overview of new drugs and indications approved in 2024 Generic Name Brand Name Manufacturer Indication(s) Month Approved*...